Compare companies
Caplin Point Laboratories Limited | Sun Pharmaceutical Industries Limited | Divi's Laboratories Limited | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 1990.65 | 1758.95 | 5839.2 | |||
Price priv. | ||||||
Number of shares, million | 76.31 | 2399.33 | 265.47 | |||
Capitalization, billion | 59.72 | 2720 | 970.26 | |||
EBITDA, billion | 6.18 | 138.36 | 25.43 | |||
EV, billion | 91.33 | 3800.17 | 907.35 | |||
Profit and loss report | ||||||
Net profit, billion | 4.57 | 95.76 | 16 | |||
Revenue, billion | 16.77 | 477.58 | 78.45 | |||
EPS | 59.9 | 39.91 | 60.27 | |||
Balance | ||||||
Assets, billion | 26.98 | 854.63 | 154.7 | |||
Debt, billion | 0.0197 | 32.74 | 0.03 | |||
Balance cost, billion | 23.16 | 636.67 | 135.71 | |||
Cash, billion | 5.5 | 92.86 | 3.63 | |||
Coefficients | ||||||
Dividend yield, % | 0.4347 | 0.7986 | 1.22 | |||
Dividend | 5 | 15.5 | 30 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 7.48 | 30.26 | 49.75 | |||
P/S | 5.77 | 8.08 | 11.61 | |||
P/BV | 4.13 | 5.75 | 6.71 | |||
P/E | 21.18 | 40.31 | 56.93 | |||
Ev/Ebitda | 14.77 | 27.47 | 35.68 | |||
Debt/Ebitda | 0.0032 | 0.2366 | 0.0012 | |||
Efficiency | ||||||
ROE | 21.79 | 16.01 | 12.15 | |||
ROA | 18.7 | 11.52 | 10.7 | |||
ROIC | 21.77 | 18.08 | 20.52 | |||
Ebitda margin | 36.88 | 28.97 | 32.42 | |||
Net margin | 27.26 | 20.05 | 20.4 | |||
Momentum | ||||||
1 week, price changes | +2.64 % | +0.0743 % | +0.3461 % | |||
1 month, price changes | +2.17 % | +8.55 % | +2.02 % | |||
3 months, price changes | -16.21 % | -4.88 % | -0.7559 % | |||
6 months, price changes | +5.11 % | -10.12 % | +7.04 % | |||
1 year, price changes | +52.82 % | +8.08 % | +69.57 % | |||
3 years, price changes | +185.65 % | +90.26 % | +28.72 % | |||
5 years, price changes | +483.4 % | +367.45 % | +172.73 % | |||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription